GHRS Stock: Price, Earnings History and SEC Filings
GH Research PLC (GHRS) last traded at $20.86, down 2.98% on the latest session and down 11.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.23 against an analyst estimate of $-0.31, a beat of 25.8%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GHRS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.23 | $-0.31 | +25.81% |
| Mar 2026 | May 14, 2026 | $-0.31 | $-0.27 | -14.81% |
| Dec 2025 | Mar 5, 2026 | $-0.23 | $-0.29 | +20.69% |
| Sep 2025 | Nov 6, 2025 | $-0.23 | $-0.23 | +0.00% |
GHRS beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GHRS
Insider filing activity
GHRS insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
GHRS news
No recent headlines found. The live terminal has the full news feed.
About GH Research PLC
GH Research PLC (GHRS) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in Ireland. Its fiscal year ends in December.